Status:
COMPLETED
Clinical Trial to Assess the Efficacy and Safety of EASYDEW MD REGEN Cream Containing Neopop-S.
Lead Sponsor:
Eun-ji Kim
Conditions:
Laser-Induced Scar
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
The purpose of this clinical study is to evaluate the effect on skin regeneration after applying EasyDew MD Regen Cream containing Neopep-S, a regeneration factor, to patients who have undergone picos...
Detailed Description
This clinical study is a researcher-led randomized control group comparative clinical study that is conducted prospectively for one month after applying medical devices for clinical research. The sub...
Eligibility Criteria
Inclusion
- Those aged 19 to 65 who have undergone picosure laser treatment on facial and body skin tissues
- Decided to participate in this clinical study and signed a written informed consent the subject
Exclusion
- Subjects with uncontrolled diabetes
- Subjects with uncontrolled hypertension and cardiovascular disease
- Subjects with hemorrhagic diseases such as hemophilia
- Immunosuppressants, corticosteroids, cytotoxic agents, and anticoagulants can affect the results Subjects who are or are scheduled to receive medication for an extended period of time
- Acute or chronic skin disease causes stage progression or active bacteria in the application area Who has a virus infection
- When the researcher's judgment determines that participation in the study is inappropriate (e.g. keloid constitution)
Key Trial Info
Start Date :
November 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05982509
Start Date
November 11 2022
End Date
July 27 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Gyeonggi-do, South Korea